MINAPHARM Pharmaceuticals (EGX:MIPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
179.60
-0.52 (-0.29%)
At close: May 13, 2025
-10.32%
Market Cap 1.99B
Revenue (ttm) 4.42B
Net Income (ttm) -190.31M
Shares Out 11.06M
EPS (ttm) -17.20
PE Ratio n/a
Forward PE n/a
Dividend 1.65 (0.92%)
Ex-Dividend Date May 8, 2024
Volume 2,219
Average Volume 1,554
Open 180.12
Previous Close 180.12
Day's Range 175.01 - 180.10
52-Week Range 145.00 - 226.50
Beta -0.17
RSI 55.40
Earnings Date May 29, 2025

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, medical and dental supplies, and dietary supplements in Egypt and internationally. The company produces veterinary and herbal medicines. It offers its products for the treatment of hematoma and thrombosis, iron deficiency anemia, recurrent urinary tract infections, immunostimulants, osteoporosis, renal osteodystrophy, loop diuretics, prophylaxis, hemorrhoids, rheumatoid arthritis, hyperlipidemia, alopecia, skin infections, topical corticosteroids, gynecological antifungals, vaginal infections, anti-... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 450
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MIPH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.